论文部分内容阅读
目的 :探讨肝动脉插管联合经皮肝穿刺选择性门静脉化疗栓塞 (TACE +SPVE)治疗不能手术的中晚期肝癌的效果。方法 :对不能手术切除的中晚期肝癌 15例在TACE术后 1周 ,行超声引导下经皮经肝穿刺选择性门静脉化疗栓塞。结果 :TACE +SPVE 15例共行 4 9次 ,治疗后肿瘤缩小 13例 ,AFP转阴 5例 ,二期手术 3例 ,1例肿瘤缩小 80 % ,AFP转阴。 1年生存率 80 % (8/ 10 )。结论 :TACE +SPVE是治疗不能手术切除的中晚期肝癌的有效方法。
Objective: To investigate the effect of hepatic arterial cannulation combined with percutaneous transhepatic selective portal vein chemoembolization (TACE + SPVE) in the treatment of inoperable advanced hepatocellular carcinoma. Methods: Fifteen patients with unresectable advanced hepatocellular carcinoma (HCC) were treated with selective transcatheter arterial chemoembolization under the guidance of ultrasound. One week after TACE. Results: There were 15 cases of TACE plus SPVE 4 times in total. After treatment, the tumor was reduced in 13 cases, AFP was negative in 5 cases, stage 2 operation in 3 cases, and in 1 case the tumor was reduced by 80% and AFP was negative. 1-year survival rate of 80% (8/10). Conclusion: TACE + SPVE is an effective method for the treatment of unresectable advanced hepatocellular carcinoma.